Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; 1. Mechanism of Chemotherapy in Cancer Treatment -- 2. Neutropenic Complications of Chemotherapy -- 3. Chemotherapy Induced Anemia -- 4. Cancer Treatment Related Thrombocytopenia -- 5. Oral Mucositis -- 6. Gastrointestinal Complications of Chemotherapy -- 7. Neurological Complications --…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
"Strategies to Mitigate the Toxicity of Cancer Therapeutics, Volume 155 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters, each of which is written by an international board of authors. Provides the authority and ex…
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
c.1 BC Cancer Agency VAN Library | Available |
Contents:; The oncological patient and aesthetic medicine: The bonded approach -- Challenges for oncology: Prevention, palliation, and survival -- Cancer as a chronic disease -- Clinical record: Oncological screening -- Tumor markers -- The psychological approach: The healing power of image and co…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Contents:; Overview of Cancer-Associated Thrombosis -- Pathophysiology and Risk Factors for Cancer-Associated Thrombosis -- Impact of Venous Thromboembolism on Cancer Survival -- Occult Cancer Workup in Idiopathic Venous Thromboembolism -- Chemotherapy Induced Thrombosis -- Catheter-Related Thrombo…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer…
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |